GenMark Diagnostics Intangible Assets

GenMark Diagnostics's intangible assets stands at $840K as of December 2020. That compares with $1.4M in the prior-year period — down 41.3% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

GenMark Diagnostics reported $840K in intangible assets versus $1.4M a year earlier — a 41.3% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $1.4M in the prior-year period — down 41.3% year over year. Sustained growth in intangible assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how GenMark Diagnostics's intangible assets evolved across reporting periods, while the comparison chart places GNMK next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, intangible assets is commonly used to spot outliers. GenMark Diagnostics's reading of $840K is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.